Curaleaf Holdings, Inc. Canadian Securities Exchange

CURA

CA23126M1023

Pharmaceuticals

End-of-day quote Canadian Securities Exchange Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		-10.77%	-10.46%

06-24	Curaleaf Introduces Hemp-Derived THC Products Line, New Consumer E-Commerce Marketplace	MT
06-24	Curaleaf Brief: Launching Hemp Derived Product Line and New Direct to Consumer Ecommerce Marketplace	MT

Curaleaf Holdings, Inc. announced that it expects to receive CAD 30 million in funding

January 09, 2019

Curaleaf Holdings, Inc. (CNSX:CURA) announced that it has entered into an agreement with the owners of HMS Health, LLC, HMS Processing LLC, HMS Sales, LLC, and MI Health LLC for convertible loan for gross proceeds of CAD 30,000,000 on January 10, 2019. The loan is convertible into common shares for proceeds of CAD 2,000,000 upon receipt of all required state and local regulatory approvals.

Latest news about Curaleaf Holdings, Inc.

Curaleaf Introduces Hemp-Derived THC Products Line, New Consumer E-Commerce Marketplace	06-24	MT
Curaleaf Brief: Launching Hemp Derived Product Line and New Direct to Consumer Ecommerce Marketplace	06-24	MT
Transcript : Curaleaf Holdings, Inc. - Shareholder/Analyst Call	06-14
KindlyMD Collaborates with Curaleaf to Expand Patient Education on Medical Cannabis Care in Utah	06-10	CI
Curaleaf "Disagrees" With Miller Amendment to 2018 Farm Bill in U.S.	05-24	MT
Curaleaf Holdings, Inc. Celebrates Miami North Biscayne Dispensary Opening	05-22	CI
Cannabis stocks rally after DOJ proposal to reclassify marijuana	05-16	RE
US Government Reclassifies Marijuana to Less-Restrictive Category	05-16	MT
Justice Department Set to Post Cannabis Reclassification Plans	05-16	MT
Needham Adjusts Price Target on Curaleaf to $6.25 From $5.25, Keeps Buy Rating	05-10	MT
Curaleaf Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Transcript : Curaleaf Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024	05-09
Curaleaf Brief: Q1 Revenue of US$339 Million	05-09	MT
Investors wary of US cannabis ETFs despite recent rally	05-07	RE
INSTANT VIEW-Biden administration plans to reclassify marijuana	04-30	RE
DEA to Move to Reclassify Marijuana, Associated Press Reports	04-30	MT
Curaleaf Brief: Completed Acquisition of Northern Green Canada	04-22	MT
Curaleaf Holdings, Inc. completed the acquisition of Northern Green Canada Inc. for approximately $16 million.	04-21	CI
Curaleaf Is Exploring Secondary Listing In Europe, Including Frankfurt And London - FT	04-05	RE
Curaleaf Holdings Agrees to Buy Northern Green Canada to Bolster European Flower Supply	03-19	MT
Curaleaf Brief: Buying Northern Green Canada to Bolster European Flower Supply	03-19	MT
Curaleaf Holdings, Inc. signed a deal to acquire Northern Green Canada Inc..	03-18	CI
Curaleaf Holdings, Inc. agreed to acquire Northern Green Canada Inc.	03-18	CI
Cannabis Stocks Gain Following Rumors of Imminent Rescheduling	03-15	DJ
Curaleaf Expanding into Czech Republic with Astrasana Pharma Partnershi	03-14	MT

Chart Curaleaf Holdings, Inc.

Duration

Period

More charts

Company Profile

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.

Sector

Pharmaceuticals

Calendar

06/08/2024 - Q2 2024 Earnings Release

More about the company